Drug Type siRNA |
Synonyms NN-6582, NN6582, NNC0582 0001 + [2] |
Target |
Action modulators |
Mechanism LXR-α modulators(nuclear receptor subfamily 1 group H member 3 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Metabolic Dysfunction Associated Steatohepatitis | Phase 1 | Austria | 14 Nov 2022 |





